Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Novartis patent term dabrafenib?Pramlintide acetate price?Dabrafenib patent expiration?Symbravo ingredients mechanism of action?Patent tenofovir alafenamide gilead?
See the DrugPatentWatch profile for Crysvita
Crysvita (burosumab) is made by Kyowa Kirin. [1]
Crysvita is prescribed for rare bone disorders caused by FGF23-related phosphate wasting, including X-linked hypophosphatemia (XLH) in children and adults. [2]
As of the information available in the provided sources, Crysvita is identified with Kyowa Kirin as the manufacturer. [1]
Other Questions About Crysvita :